EssilorLuxottica : Technically solid
Entry price | Target | Stop-loss | Potential |
---|
€173.2 |
€186.28 |
€165.12 |
+7.55% |
---|
EssilorLuxottica's shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Summary● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths● The earnings growth currently anticipated by analysts for the coming years is particularly strong.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.73 times its estimated earnings per share for the ongoing year.
● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.